{"id":"l-alanyl-l-glutamine","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Fluid overload"},{"rate":null,"effect":"Electrolyte imbalances"},{"rate":null,"effect":"Infusion site reactions"}]},"_chembl":{"chemblId":"CHEMBL3707366","moleculeType":"Small molecule","molecularWeight":"217.22"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This dipeptide formulation delivers two conditionally essential amino acids—alanine and glutamine—that play critical roles in protein metabolism, immune function, and gut barrier integrity. Glutamine serves as a primary fuel source for enterocytes and immune cells, while alanine participates in gluconeogenesis and the glucose-alanine cycle. The combination is designed to improve nitrogen balance and reduce muscle catabolism in clinical settings such as critical illness or major surgery.","oneSentence":"L-Alanyl/L-Glutamine is a dipeptide that provides essential amino acids to support protein synthesis and cellular metabolism, particularly in critically ill or nutritionally compromised patients.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:59.343Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Nutritional support in critically ill patients"},{"name":"Post-operative metabolic support"},{"name":"Patients with impaired gastrointestinal function requiring parenteral or enteral nutrition"}]},"trialDetails":[{"nctId":"NCT03967795","phase":"NA","title":"Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2019-11-28","conditions":"Enteral Nutrition, Intensive Care Unit, Biomarkers","enrollment":73},{"nctId":"NCT04305769","phase":"PHASE2","title":"Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2021-06-01","conditions":"Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea","enrollment":260},{"nctId":"NCT06339372","phase":"NA","title":"Perioperative Supplementation With Immunonutrition and Its Impact on Surgical Outcome and Pain in Oral Cavity or Mandibular Tumours","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-02-01","conditions":"Immunonutrition, Surgical Outcome, Pain","enrollment":176},{"nctId":"NCT05822518","phase":"NA","title":"Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2022-06-01","conditions":"Cancer, Bladder, Cystostomy; Complications","enrollment":42},{"nctId":"NCT04560309","phase":"PHASE3","title":"Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF","status":"COMPLETED","sponsor":"National Cardiovascular Center Harapan Kita Hospital Indonesia","startDate":"2021-01-01","conditions":"Coronary Artery Bypass, Cardiopulmonary Bypass, Coronary Artery Disease","enrollment":60},{"nctId":"NCT06065566","phase":"NA","title":"Effect of Parenteral Glutamine on Myocardial Injury and Inflammation Biomarkers","status":"COMPLETED","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2020-02-04","conditions":"Insufficiency;Cardiac","enrollment":56},{"nctId":"NCT05586646","phase":"NA","title":"Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients","status":"UNKNOWN","sponsor":"Air Force Specialized Hospital, Cairo, Egypt","startDate":"2022-04-01","conditions":"Pressure Ulcer","enrollment":200},{"nctId":"NCT03445221","phase":"PHASE2, PHASE3","title":"Preoperative Immunonutrition and Cardiac Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2018-08-01","conditions":"Cardiac Function","enrollment":60},{"nctId":"NCT02053350","phase":"PHASE2","title":"Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2015-04","conditions":"Clostridium Difficile Infection","enrollment":7},{"nctId":"NCT00647036","phase":"PHASE4","title":"Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving Glutamine","status":"COMPLETED","sponsor":"Institute of Child Health","startDate":"2009-07","conditions":"Surgical Infants Requiring Total Parenteral Nutrition","enrollment":60},{"nctId":"NCT05140772","phase":"PHASE2, PHASE3","title":"Glutamine Effects in Burn Patients","status":"UNKNOWN","sponsor":"Menoufia University","startDate":"2020-06-01","conditions":"Drug Effect","enrollment":60},{"nctId":"NCT04909905","phase":"PHASE3","title":"Glutamine Supplementation and Short-term Mortality in Covid-19","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-05-30","conditions":"Covid19","enrollment":60},{"nctId":"NCT01701193","phase":"PHASE1, PHASE2","title":"A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions","status":"COMPLETED","sponsor":"Temple Therapeutics BV","startDate":"2015-02-15","conditions":"Pelvic Adhesions","enrollment":47},{"nctId":"NCT00133978","phase":"NA","title":"Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients","status":"COMPLETED","sponsor":"Daren K. Heyland","startDate":"2005-04","conditions":"Critical Illness, Sepsis, Multiple Organ Failure","enrollment":1223},{"nctId":"NCT01534663","phase":"PHASE2, PHASE3","title":"Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure","status":"COMPLETED","sponsor":"Columbia University","startDate":"2011-11","conditions":"Heart Failure","enrollment":31},{"nctId":"NCT04019184","phase":"PHASE3","title":"Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2019-07-18","conditions":"Cardiac Surgery, Acute Kidney Injury","enrollment":64},{"nctId":"NCT01704664","phase":"NA","title":"Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients","status":"UNKNOWN","sponsor":"Medical University of Bialystok","startDate":"2007-03","conditions":"Gastric Cancer","enrollment":240},{"nctId":"NCT03341169","phase":"NA","title":"Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2018-03-20","conditions":"Aortic Valve Stenois","enrollment":108},{"nctId":"NCT03589495","phase":"PHASE4","title":"Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-07-30","conditions":"Systemic Inflammatory Response Syndrome","enrollment":60},{"nctId":"NCT00248638","phase":"PHASE3","title":"Efficacy and Mechanisms of GLN Dipeptide in the SICU","status":"COMPLETED","sponsor":"Emory University","startDate":"2006-09","conditions":"Critical Illness","enrollment":150},{"nctId":"NCT01832636","phase":"PHASE3","title":"Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2013-10","conditions":"Malnutrition, Environmental Enteropathy, Diarrhea","enrollment":112},{"nctId":"NCT01955772","phase":"PHASE3","title":"Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.","status":"UNKNOWN","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2013-11","conditions":"Myeloablative Allo-SCT","enrollment":240},{"nctId":"NCT01353638","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis","status":"TERMINATED","sponsor":"Christoph Aufricht","startDate":"2011-04","conditions":"End Stage Renal Disease","enrollment":25},{"nctId":"NCT01794884","phase":"PHASE2","title":"Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery","status":"COMPLETED","sponsor":"Yuejiang Liu","startDate":"2013-01","conditions":"Rheumatic Heart Disease, Coronary Heart Disease","enrollment":33},{"nctId":"NCT02130674","phase":"PHASE4","title":"Optimized Therapy in Severe Traumatic Brain Injured Patients","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2005-01","conditions":"Traumatic Brain Injury, Coma","enrollment":12},{"nctId":"NCT00875797","phase":"PHASE4","title":"Enteral Versus Parenteral Glutamine Supplement","status":"TERMINATED","sponsor":"University Medical Centre Ljubljana","startDate":"2004-10","conditions":"Critically Ill","enrollment":90},{"nctId":"NCT01478126","phase":"PHASE3","title":"Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2012-01","conditions":"Coronary Artery Disease","enrollment":24},{"nctId":"NCT01367223","phase":"PHASE4","title":"Modulation of Systemic Inflammatory Response in Critically Ill Children After Glutamine Supplementation","status":"COMPLETED","sponsor":"Hospital Sant Joan de Deu","startDate":"2010-04","conditions":"Inflammatory Response, Multi-organ Failure","enrollment":101},{"nctId":"NCT00213668","phase":"PHASE4","title":"Effect of Glutamine on Gastric Emptying and Length of Parenteral Nutrition in Premature Neonates","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2002-04","conditions":"Enteral Feeding","enrollment":""},{"nctId":"NCT01831310","phase":"PHASE4","title":"Nutrition for Colorectal Cancer Patients and Neutrophil Functions","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2007-01","conditions":"Malnutrition, Colorectal Cancer","enrollment":36},{"nctId":"NCT01240291","phase":"PHASE3","title":"The Clinical Role of Intravenous Glutamine in Trauma Patients Receiving Enteral Nutrition","status":"UNKNOWN","sponsor":"Royal Brisbane and Women's Hospital","startDate":"2011-03","conditions":"Multiple Trauma, Critically Ill","enrollment":88},{"nctId":"NCT00922688","phase":"NA","title":"Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients","status":"UNKNOWN","sponsor":"Medical Center Alkmaar","startDate":"2010-12","conditions":"Colon Carcinoma","enrollment":30},{"nctId":"NCT01250782","phase":"PHASE2","title":"Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.","status":"UNKNOWN","sponsor":"Hospital Universitari Son Dureta","startDate":"2010-10","conditions":"Trauma ICU Patients","enrollment":150},{"nctId":"NCT01250080","phase":"NA","title":"Effect of Gutamine Administration in the Innate Immune System Response in ICU Patients.","status":"COMPLETED","sponsor":"Hospital Universitari Son Dureta","startDate":"2007-01","conditions":"Moderate to Severe Trauma, as Defined by an, Injury Severity Score (ISS) > 12 Points Were Included in the Study.","enrollment":43},{"nctId":"NCT00922714","phase":"PHASE4","title":"Scandinavian Intensive Care Unit (ICU) Glutamine Study","status":"TERMINATED","sponsor":"Scandinavian Critical Care Trials Group","startDate":"2003-10","conditions":"ICU Patients","enrollment":1000},{"nctId":"NCT00133562","phase":"PHASE3","title":"HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2004-08","conditions":"Diarrhea, Malnutrition, Other Nutritional Deficiencies","enrollment":108},{"nctId":"NCT00338221","phase":"PHASE3","title":"Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2004-08","conditions":"Diarrhea, Malnutrition","enrollment":108},{"nctId":"NCT00732849","phase":"PHASE4","title":"The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2002-06","conditions":"Gastrointestinal Surgery","enrollment":600},{"nctId":"NCT00558155","phase":"PHASE4","title":"The Impact of Immunostimulating Nutrition on the Outcome of Surgery","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2001-06","conditions":"Gastric Cancer, Pancreatic Cancer","enrollment":214}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":162,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Evitar"],"phase":"phase_3","status":"active","brandName":"L-Alanyl/L-Glutamine","genericName":"L-Alanyl/L-Glutamine","companyName":"University Hospital Muenster","companyId":"university-hospital-muenster","modality":"Small molecule","firstApprovalDate":"","aiSummary":"L-Alanyl/L-Glutamine is a dipeptide that provides essential amino acids to support protein synthesis and cellular metabolism, particularly in critically ill or nutritionally compromised patients. Used for Nutritional support in critically ill patients, Post-operative metabolic support, Patients with impaired gastrointestinal function requiring parenteral or enteral nutrition.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}